Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus
- PMID: 34522039
- PMCID: PMC8439173
- DOI: 10.1038/s41582-021-00549-x
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus
Erratum in
-
Publisher Correction: Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.Nat Rev Neurol. 2021 Nov;17(11):724. doi: 10.1038/s41582-021-00579-5. Nat Rev Neurol. 2021. PMID: 34625724 Free PMC article. No abstract available.
Abstract
Dysregulation of the immune system is a cardinal feature of Alzheimer disease (AD), and a considerable body of evidence indicates pathological alterations in central and peripheral immune responses that change over time. Considering AD as a systemic immune process raises important questions about how communication between the peripheral and central compartments occurs and whether this crosstalk represents a therapeutic target. We established a whitepaper workgroup to delineate the current status of the field and to outline a research prospectus for advancing our understanding of peripheral-central immune crosstalk in AD. To guide the prospectus, we begin with an overview of seminal clinical observations that suggest a role for peripheral immune dysregulation and peripheral-central immune communication in AD, followed by formative animal data that provide insights into possible mechanisms for these clinical findings. We then present a roadmap that defines important next steps needed to overcome conceptual and methodological challenges, opportunities for future interdisciplinary research, and suggestions for translating promising mechanistic studies into therapeutic interventions.
© 2021. Springer Nature Limited.
Conflict of interest statement
M.G.T. is a member of the Medical Scientific Advisory Group to the Alzheimer’s Association and a consultant to INmune Bio. G.D. is listed as an inventor on patent WO2014206899A1 related to a peripheral immunomodulatory approach for treating Alzheimer disease and related disorders, and on patent WO2018172540A1 related to peripheral immune biomarkers for predicting the progression of Alzheimer disease. The other authors declare no competing interests.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
